How much is a Nuro stock worth?
Apr 15, 2022 · NeuroMetrix's stock was trading at $1.41 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NURO shares have increased by 184.4% and is now trading at $4.01. View which stocks have been most impacted by COVID-19. Are investors shorting NeuroMetrix?
Is NeuroMetrix (Nuro) stock a buy in 2021?
NURO | Complete NeuroMetrix Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Will NeuroMetrix (Nuro) outperform the S&P 500 over the long term?
Apr 08, 2022 · Real-time trade and investing ideas on NeuroMetrix Inc. NURO from the largest community of traders and investors.
What is the ticker symbol for NeuroMetrix?
Apr 11, 2022 · NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to ...
Is Nuro a public company?
Nuro is an American robotics company based in Mountain View, California and founded by Jiajun Zhu and Dave Ferguson....Nuro.TypePrivateIndustryRoboticsFounded2016HeadquartersMountain View, California , U.S.Key peopleJiajun Zhu (Co-founder) Dave Ferguson (Co-founder)2 more rows
Can you buy Nuro stock?
Shares of NURO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Is Nuro stock a buy or sell?
Is NEUROMETRIX Stock a good buy in 2022, according to Wall Street analysts? The consensus among 1 Wall Street analyst covering (NASDAQ: NURO) stock is to Strong Buy NURO stock.
What is neuro stock?
$ 3.9000CloseChgChg %$4.0100-0.1200-2.91%
Where is Nuro available?
Nuro has brought autonomous delivery to local communities in Texas , Arizona , and California—for less driving and more thriving.Apr 12, 2021
Who owns Nuro stock?
Top 10 Owners of NeuroMetrix IncStockholderStakeShares ownedThe Vanguard Group, Inc.4.19%293,121Renaissance Technologies LLC2.07%144,738Dimensional Fund Advisors LP0.73%50,975BlackRock Fund Advisors0.54%38,0506 more rows
Will Nuro stock go up?
This may be an early warning and the risk will be increased slightly over the next couple of days....Predicted Opening Price for NeuroMetrix of Monday, April 18, 2022.Fair opening price April 18, 2022Current price$4.04$4.01 (Undervalued)
What is the future for Nuro stock?
Stock Price Forecast The 1 analysts offering 12-month price forecasts for NeuroMetrix Inc have a median target of 50.00, with a high estimate of 50.00 and a low estimate of 50.00. The median estimate represents a +1,165.82% increase from the last price of 3.95.
Why did Nuro stock go up?
NeuroMetrix (NASDAQ:NURO) stock is surging higher on Tuesday after getting “Breakthrough Device Designation” from the U.S. Food and Drug Administration (FDA). The breakthrough designation is for NeuroMetrix's Quell device designed to treat symptoms in adult patients suffering from fibromyalgia.Jul 20, 2021
Is Nuro the same as NeuroMetrix?
NeuroMetrix (NASDAQ:NURO) stock is on the rise Tuesday despite a lack of news concerning the company. To go along with the increase to NURO stock, the company is seeing heavy trading of its shares. This has more than 57 million shares traded as of this writing.Dec 8, 2020
How has NeuroMetrix's stock been impacted by Coronavirus?
NeuroMetrix's stock was trading at $1.41 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (W...
Are investors shorting NeuroMetrix?
NeuroMetrix saw a drop in short interest in the month of February. As of February 28th, there was short interest totaling 92,600 shares, a drop of...
When is NeuroMetrix's next earnings date?
NeuroMetrix is scheduled to release its next quarterly earnings announcement on Thursday, April 28th 2022. View our earnings forecast for NeuroMet...
How were NeuroMetrix's earnings last quarter?
NeuroMetrix, Inc. (NASDAQ:NURO) posted its quarterly earnings data on Thursday, January, 27th. The medical device company reported ($0.15) earnings...
When did NeuroMetrix's stock split? How did NeuroMetrix's stock split work?
NeuroMetrix shares reverse split before market open on Friday, May 12th 2017. The 1-8 reverse split was announced on Thursday, May 11th 2017. The n...
Who are NeuroMetrix's key executives?
NeuroMetrix's management team includes the following people: Shai N. Gozani , Chairman, President & Chief Executive Officer Thomas T. Higgins ,...
What is Shai N. Gozani's approval rating as NeuroMetrix's CEO?
10 employees have rated NeuroMetrix CEO Shai N. Gozani on Glassdoor.com . Shai N. Gozani has an approval rating of 57% among NeuroMetrix's employe...
Who are some of NeuroMetrix's key competitors?
Some companies that are related to NeuroMetrix include iCAD (ICAD) , PolyPid (PYPD) , Nemaura Medical (NMRD) , Neuronetics (STIM) , TransEnter...
What other stocks do shareholders of NeuroMetrix own?
Based on aggregate information from My MarketBeat watchlists, some companies that other NeuroMetrix investors own include Merit Medical Systems (M...
What stocks does MarketBeat like better than NeuroMetrix?
Are investors shorting NeuroMetrix?
Wall Street analysts have given NeuroMetrix a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but NeuroMetrix wasn't one of them.
When is NeuroMetrix's next earnings date?
NeuroMetrix saw a drop in short interest in the month of August. As of August 13th, there was short interest totaling 423,400 shares, a drop of 66.9% from the July 29th total of 1,280,000 shares. Based on an average daily trading volume, of 7,920,000 shares, the days-to-cover ratio is presently 0.1 days.#N#View NeuroMetrix's Short Interest.
How were NeuroMetrix's earnings last quarter?
NeuroMetrix is scheduled to release its next quarterly earnings announcement on Thursday, October 28th 2021.#N#View our earnings forecast for NeuroMetrix.
How has NeuroMetrix's stock been impacted by COVID-19 (Coronavirus)?
NeuroMetrix, Inc. (NASDAQ:NURO) posted its earnings results on Thursday, July, 22nd. The medical device company reported ($0.13) earnings per share (EPS) for the quarter. The medical device company had revenue of $2.21 million for the quarter.
When did NeuroMetrix's stock split? How did NeuroMetrix's stock split work?
NeuroMetrix's stock was trading at $1.41 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, NURO shares have increased by 671.6% and is now trading at $10.88.#N#View which stocks have been most impacted by COVID-19.
What is Shai N. Gozani's approval rating as NeuroMetrix's CEO?
Shares of NeuroMetrix reverse split on Friday, May 12th 2017. The 1-8 reverse split was announced on Thursday, May 11th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 11th 2017. An investor that had 100 shares of NeuroMetrix stock prior to the reverse split would have 13 shares after the split.
About NURO
10 employees have rated NeuroMetrix CEO Shai N. Gozani on Glassdoor.com. Shai N. Gozani has an approval rating of 57% among NeuroMetrix's employees. This puts Shai N. Gozani in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.
Financial Performance
NeuroMetrix, Inc., a healthcare company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders.
News
In 2020, NeuroMetrix's revenue was $7.38 million, a decrease of -20.43% compared to the previous year's $9.27 million. Losses were -$2.09 million, -44.55% less than in 2019.
28 Stocks Moving in Monday's Pre-Market Session
The stock market is usually not very exciting on the last day of the week. But some stocks still tend to stir things up a little bit.
What's Going On With NeuroMetrix Shares Today?
Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) rose 86.1% to $9.87 in pre-market trading after jumping over 80% on Friday. The company recently reported a Q2 loss of $5.13 per share. Affirm Holdings, Inc. (NASDAQ: AFRM) rose 36.4% to $92.60 in pre-market trading announced a partnership with Amazon.com Inc.
35 Stocks Moving In Friday's Mid-Day Session
NeuroMetrix Inc (NASDAQ: NURO) shares are surging higher Friday on abnormally high volume amid an increase in retail investor interest around the low-float stock. The average session volume is just under 8 million. The trading volume for Friday's session was nearing 50 million at publication time.
NURO Stock: 9 Things to Know About NeuroMetrix as Meme Stock Investors Send Shares Soaring
Gainers Support.com, Inc. (NASDAQ: SPRT) shares climbed 87% to $36.83 on abnormally high volume amid continued volatility. The stock has recently been mentioned as a potential short squeeze play by traders on social media. Navios Maritime Acquisition Corporation (NYSE: NNA) jumped 49.4% to $3.1382. Navios Maritime Partners L.P.
22 Stocks Moving in Friday's Pre-Market Session
NeuroMetrix (NASDAQ:NURO) is rocketing higher on Friday as retail investors short-squeeze share of the company’s stock. Source: Shutterstock Retail traders are taking to social media to push shares of NURO stock higher today.
Support.com and NeuroMetrix Stocks Soar on Meme Boost
Gainers RenovoRx, Inc. (NASDAQ: RNXT) rose 106% to $15.00 in pre-market trading. RenovoRx shares dropped 19% on Thursday as the company priced its IPO at $9 per unit. Support.com, Inc. (NASDAQ: SPRT) rose 44.7% to $28.50 in pre-market trading on abnormally high volume. The company’s shares jumped over 41% on Thursday.
Companies Like NeuroMetrix (NASDAQ:NURO) Can Afford To Invest In Growth
Support.com and NeuroMetrix were soaring in premarket trading Friday as the companies continued to be touted by the retail investing crowd. Support.com, which provides cloud-based software and services, was up nearly 60% to $31.20, while the biopharma NeuroMetrix climbed nearly 30% to $12.80.
Signals & Forecast
Just because a business does not make any money, does not mean that the stock will go down. Indeed, NeuroMetrix...
Support, Risk & Stop-loss
Furthermore, there is a buy signal from the 3 months Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development.
Is NeuroMetrix stock A Buy?
On the downside, the stock finds support just below today's level from accumulated volume at $10.56 and $10.41. There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, NeuroMetrix finds support just below today's level at $10.56.
NURO Stock at a Glance
NeuroMetrix holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
A Real Breakthrough
Prior to July of 2021, NURO stock was what could informally be called a penny stock, trading for less than $5 per share. Then, things got a little bit hectic. Without warning, the bulls ramped the share price up to $10 on Jul. 20 — and then all the way past $38 the next day.
Getting Results
Since its run, NURO stock has backed off somewhat, landing at about $16 on Jul. 29. Therefore, traders might choose to add some shares at the recently reduced price point. Just maybe, there could be another major short squeeze in the works soon.
The Takeaway on NURO Stock
There’s a definite medical need here, as fibromyalgia affects an estimated 2% of the U.S. population, if not more. That’s over 5 million people suffering from a condition that can cause terrible chronic pain.
